Samyang Biopharm Demonstrates Lifting Procedure at International Conference
[Asia Economy Reporter Choi Dae-yeol] Samyang Biopharm will participate in the International Master Course on Aging Science (IMCAS) Asia 2020, held online from the 17th, to demonstrate its lifting thread brand Croquis. IMCAS is one of the world's top three aesthetic surgery conferences, and this event targeting the Asian region is being held for the 14th year this year.
Croquis is an aesthetic surgery thread developed by Samyang Biopharm, named after the art technique of sketching the subject's features. It signifies quickly and naturally defining facial contours. For this event, they have prepared a procedure video and a lecture where Dr. Choi Ho-seong, head of Pionah Clinic, will perform the procedure live.
Hot Picks Today
"Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Jay Y. Lee Bows His Head: "I Will Face the Harsh Storm"...Apologizes for Samsung Labor-Management Conflict
- 200 Billion Won in Additional Loans Amid Ongoing Trial for 180 Billion Won Illegal Lending? Saemaeul Geumgo Reported to Police
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Stop Tying Others' Hands"... China Criticizes U.S. Containment Policy
Considering that the company is a latecomer in the aesthetic surgery thread sector, it is focusing on establishing various scientific evidences. While existing aesthetic surgery thread brands mainly emphasize before-and-after procedure comparison effects, this company is collecting data that can prove the correlation between the effects of procedures on different facial areas and the physical properties of the threads. The company also plans to participate in the Anti-Aging and Aesthetic Medicine World Congress (AMWC), held over three days starting from the 5th of next month, to present analysis results of overseas research cases.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.